Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where M Tachrount is active.

Publication


Featured researches published by M Tachrount.


Annals of Neurology | 2016

Cause and prevention of demyelination in a model multiple sclerosis lesion

Roshni Desai; Andrew L. Davies; M Tachrount; Marianne Kasti; Frida Laulund; Xavier Golay; Kenneth Smith

Demyelination is a cardinal feature of multiple sclerosis, but it remains unclear why new lesions form, and whether they can be prevented. Neuropathological evidence suggests that demyelination can occur in the relative absence of lymphocytes, and with distinctive characteristics suggestive of a tissue energy deficit. The objective was to examine an experimental model of the early multiple sclerosis lesion and identify pathogenic mechanisms and opportunities for therapy.


Annals of clinical and translational neurology | 2017

Neurite dispersion: a new marker of multiple sclerosis spinal cord pathology?

F Grussu; Torben Schneider; Carmen Tur; Richard L. Yates; M Tachrount; Andrada Ianuş; M Yiannakas; Jia Newcombe; Hui Zhang; Daniel C. Alexander; Gabriele C. DeLuca; C Wheeler-Kingshott

Conventional magnetic resonance imaging (MRI) of the multiple sclerosis spinal cord is limited by low specificity regarding the underlying pathological processes, and new MRI metrics assessing microscopic damage are required. We aim to show for the first time that neurite orientation dispersion (i.e., variability in axon/dendrite orientations) is a new biomarker that uncovers previously undetected layers of complexity of multiple sclerosis spinal cord pathology. Also, we validate against histology a clinically viable MRI technique for dispersion measurement (neurite orientation dispersion and density imaging,NODDI), to demonstrate the strong potential of the new marker.


Brain Pathology | 2016

Combined Ex Vivo 9.4T MRI and Quantitative Histopathological Study in Normal and Pathological Neocortical Resections in Focal Epilepsy

Cheryl Reeves; M Tachrount; David L. Thomas; Zuzanna Michalak; Joan Liu; Matthew Ellis; Beate Diehl; Anna Miserocchi; Andrew W. McEvoy; Sofia H. Eriksson; Tarek A. Yousry; Maria Thom

High‐resolution magnetic resonance imaging (MRI) may improve the preoperative diagnosis of focal cortical dysplasia (FCD) in epilepsy. Quantitative 9.4T MRI was carried out (T1, T2, T2* and magnetization transfer ratio) on 13 cortical resections, representing pathologically confirmed FCD (five cases) and normal cortex. Quantitative immunohistochemistry for myelination (myelin basic protein/SMI94), neuronal populations [microtubule‐associated protein 2 (MAP2), neurofilament (SMI31, SMI32), synaptophysin, NeuN, calbindin], reactive glia (GFAP), microglia (CD68) and blood–brain barrier permeability (albumin) was carried out in 43 regions of interest (ROI) from normal and abnormal white matter and cortex. MRI was spatially aligned and quantitative analysis carried out on corresponding ROI. Line profile analysis (LPA) of intensity gradients through the cortex was carried out on MRI and immunostained sections. An inverse correlation was noted between myelin/SMI94 and T1, T2 (P < 0.005) and T2* (P < 0.05; Spearmans correlation) and a positive correlation between neuronal MAP2 and T1 (P < 0.005) and T2* (P < 0.05) over all ROI. Similar pathology–MRI correlations were observed for histologically unremarkable white matter ROI only. LPA showed altered gradient contours in regions of FCD, reflecting abnormal cortical lamination and myelo‐architecture, including a preoperatively undetected FCD case. This study demonstrates the ability of quantitative 9.4T MRI to detect subtle differences in neuronal numbers and myelination in histologically normal appearing white matter and LPA in the evaluation of cortical dyslamination. These methods may be translatable to the in vivo detection of mild cortical malformations.


Annals of Neurology | 2016

Early lipofuscin accumulation in Frontal Lobe Epilepsy

Joan Y. W. Liu; Cheryl Reeves; Beate Diehl; Antonietta Coppola; Aliya Al‐Hajri; Chandrashekar Hoskote; Salim al Mughairy; M Tachrount; Michael J. Groves; Zuzanna Michalak; Kevin Mills; Andrew W. McEvoy; Anna Miserocchi; Sanjay M. Sisodiya; Maria Thom

This study reports on a novel brain pathology in young patients with frontal lobe epilepsy (FLE) that is distinct from focal cortical dysplasia (FCD).


Neurobiology of Disease | 2019

Melatonin as an adjunct to therapeutic hypothermia in a piglet model of neonatal encephalopathy: A translational study

Nicola J. Robertson; Kathryn Martinello; Ingran Lingam; Adnan Avdic-Belltheus; Christopher Meehan; Daniel Alonso-Alconada; Sara Ragab; A Bainbridge; Magdalena Sokolska; M Tachrount; Benita Middleton; David C. Price; Mariya Hristova; Xavier Golay; Annamaria Soliani Raschini; Giancarlo Aquino; Nicola Pelizzi; Fabrizio Facchinetti

Therapeutic hypothermia is only partially protective for neonatal encephalopathy; there is an urgent need to develop treatments that augment cooling. Our objective was to assess safety, efficacy and pharmacokinetics of 5 and 15 mg/kg/24 h melatonin (proprietary formulation) administered at 2 h and 26 h after hypoxia-ischemia (HI) with cooling in a piglet model. Following moderate cerebral HI, 30 piglets were eligible and randomized to: i) Hypothermia (33.5 °C, 2-26 h) and vehicle (HT + V;n = 13); b) HT and 5 mg/kg melatonin over 6 h at 2 h and 26 h after HI (HT + Mel-5;n = 4); c) HT and 15 mg/kg melatonin over 6 h at 2 h and 26 h after HI (HT + Mel-15;n = 13). Intensive care was maintained for 48 h; brain MRS was acquired and cell death (TUNEL) evaluated at 48 h. Comparing HT + V with HT + Mel-5 and HT + Mel-15, there was no difference in blood pressure or inotropic support needed, brain Lactate/N Acetylaspartate at 24 h and 48 h was similar, ATP/phosphate pool was higher for HT + Mel-15 versus HT + V at 24 h (p = 0.038) but not 48 h. A localized reduction in TUNEL positive cell death was observed in the sensorimotor cortex in the 15 mg/kg melatonin group (HT + Mel-15 versus HT + V; p < 0.003) but not in the 5 mg/kg melatonin group (HT + Mel-5 versus HT + V; p = 0.808). Putative therapeutic melatonin levels were reached 8 h after HI (104 increase from baseline; ~15-30 mg/l). Mean ± SD peak plasma melatonin levels after the first infusion were 0.0014 ± 0.0012 mg/l in the HT + V group, 3.97 ± 1.53 mg/l in the HT + Mel-5 group and 16.8 ± 8.3 mg/l in the HT + Mel-15 group. Protection was dose dependent; 15 mg/kg melatonin started 2 h after HI, given over 6 h, was well tolerated and augmented hypothermic protection in sensorimotor cortex. Earlier attainment of therapeutic plasma melatonin levels may optimize protection by targeting initial events of reperfusion injury. The time window for intervention with melatonin, as adjunct therapy with cooling, is likely to be narrow and should be considered in designing future clinical studies.


Journal of Neuropathology and Experimental Neurology | 2018

Effect of Fluorinert on the Histological Properties of Formalin-Fixed Human Brain Tissue

Juan Eugenio Iglesias; Shauna Crampsie; C Strand; M Tachrount; David L. Thomas; Janice L. Holton

Abstract Fluorinert (perfluorocarbon) represents an inexpensive option for minimizing susceptibility artifacts in ex vivo brain MRI scanning, and provides an alternative to Fomblin. However, its impact on fixed tissue and histological analysis has not been rigorously and quantitatively validated. In this study, we excised tissue blocks from 2 brain regions (frontal pole and cerebellum) of 5 formalin-fixed specimens (2 progressive supranuclear palsy cases, 3 controls). We excised 2 blocks per region per case (20 blocks in total), one of which was subsequently immersed in Fluorinert for a week and then returned to a container with formalin. The other block from each region was kept in formalin for use as control. The tissue blocks were then sectioned and histological analysis was performed on each, including routine stains and immunohistochemistry. Visual inspection of the stained histological sections by an experienced neuropathologist through the microscope did not reveal any discernible differences between any of the samples. Moreover, quantitative analysis based on automated image patch classification showed that the samples were almost indistinguishable for a state-of-the-art classifier based on a deep convolutional neural network. The results showed that Fluorinert has no effect on subsequent histological analysis of the tissue even after a long (1 week) period of immersion, which is sufficient for even the lengthiest scanning protocols.


In: (Proceedings) International Society for Magnetic Resonance in Medicine (ISMRM) 23rd Scientific Meeting and Exhibition. (pp. 0909-0909). (2015) | 2015

Histological metrics confirm microstructural characteristics of NODDI indices in multiple sclerosis spinal cord

F Grussu; T Schneider; Richard L. Yates; M Tachrount; Jia Newcombe; H Zhang; Daniel C. Alexander; Gabriele C. DeLuca; Cam Wheeler-Kingshott


In: (Proceedings) ISMRM 2018, International Society for Magnetic Resonance in Medicine, 16-21 June 2018, Paris, France. (2018) (In press). | 2018

Are we seeing any better? A comprehensive comparison of myelin biomarkers in the healthy and multiple sclerosis post mortem spinal cord

M Battiston; T Schneider; F Grussu; Geert J. Schenk; S Wergeland; M Tachrount; M Yiannakas; C Tur Gomez; Jjg Geurts; Cam Wheeler-Kingshott; Rs Samson


Presented at: ISMRM 23rd Annual Meeting, Singapore. (2016) | 2016

Quantitative Measurements of the Spinal Cord Blood Flow of an Animal Model of Relapsing-Remitting MS

M Tachrount; A Davies; R Desai; K Smith; David L. Thomas; X Golay


22nd Annual Meeting of the Organization for Human Brain Mapping (OHBM) | 2016

Fast ex vivo quantitative multiparameter mapping (MPM) of R1, R2* & MT with 100μm resolution at 9.4T

Kerrin Pine; M Tachrount; Luke Edwards; Martina F. Callaghan; Xavier Golay; Nikolaus Weiskopf

Collaboration


Dive into the M Tachrount's collaboration.

Top Co-Authors

Avatar

David L. Thomas

University College London

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

F Grussu

UCL Institute of Neurology

View shared research outputs
Top Co-Authors

Avatar

T Schneider

UCL Institute of Neurology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Maria Thom

UCL Institute of Neurology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Cheryl Reeves

UCL Institute of Neurology

View shared research outputs
Top Co-Authors

Avatar

H Zhang

University College London

View shared research outputs
Researchain Logo
Decentralizing Knowledge